Pier Luigi Piovano

Outcomes of First-Generation EGFR-TKIs Against Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Post Hoc Analysis of the BE-POSITIVE Study

Sara Pilotto, Antônio Rossi, Tiziana Vavalà et al. · Clinical Lung Cancer · 2017 · 46 citations

Medicine, Oncology, Molecular Oncology +9

BE-POSITIVE: Beyond progression after tyrosine kinase inhibitor in EGFR- positive non small cell lung cancer patients

Tiziana Vavalà, Alessandro Follador, Marcello Tiseo et al. · Lung Cancer · 2016 · 16 citations · Full text

Medicine, Oncology, Pharmacology +14

Do pacifiers cause latex allergy?

A. Venuta, P Bertolani, Patrizia Pepe et al. · Allergy · 1999 · 13 citations

Life Sciences, Otolaryngology, Allergy +8

Be-TeaM: An Italian real-world observational study on second-line therapy for EGFR-mutated NSCLC patients

Maria Lucia Reale, Rita Chiari, Marcello Tiseo et al. · Lung Cancer · 2019 · 13 citations · Full text

Medicine, Oncology, Molecular Oncology +5

Safety of extended interval dosing immune checkpoint inhibitors: a multicenter cohort study

Luca Cantini, Francesco Paoloni, Federica Pecci et al. · JNCI Journal of the National Cancer Institute · 2023 · 10 citations · Full text

Medicine, Oncology, Pharmacology +17